Advancing Science Through Research

Primary tabs

Advancing Science Through Research

At Bristol-Myers Squibb, we stand on the frontier of new possibilities regarding patient care. New medicines. New delivery systems. New hope.

The potential is real. The opportunities are endless.

Since late 2002, our R&D team has helped to bring to patients many new medicines to treat cancer, serious mental illness, HIV/AIDS, hepatitis B, rheumatoid arthritis, cardiovascular disease, organ transplant and diabetes. While our focus continues in many of these areas, we are also expanding our efforts to other diseases where the science beckons and the patient need is evident.

Our R&D strategy is to pursue significant areas of unmet medical need by leveraging our legacy in discovering and developing small molecules as well as our growing experience and expertise in biologic proteins.

As we look ahead to the future, our focus remains on building a pipeline of innovative therapies that expand the frontiers of biomedical research.

Most of all, our future depends on the people who work here. Each day, all around the world, we come to work committed to our Company mission: to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. This is our North Star.

Learn more here


Join Bristol-Myers Squibb Online:





Content from this campaign

Bristol-Myers Squibb Studying Impact of Cancer Survivorship
Bristol-Myers Squibb is committed to studying the impact on survivorship throughout the continuum of cancer care with the goal improving communication between patients and their care teams about quality of survival in cancer. Research on the survivorship concept shows us that this is a growing concern, but there is a lack of a standardized definition and appropriate...
Feb 26, 2016 10:00 AM ET
Meet Biff: A Cancer Clinical Trial Patient
Meet Frederick (also known as Biff), a cancer patient who has gone through a Bristol-Myers Squibb clinical trial. Biff is a proud grandfather of six and talked to his doctor about whether a clinical trial option was an option for him. LINKS TO RELATED RESOURCES:;...
Feb 9, 2016 10:05 AM ET
Bristol-Myers Squibb and UCLA Enter into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Research Program
Monday, December 14, 2015 6:59 am EST, NEW YORK- /3BL Media/ - ...
Dec 14, 2015 7:00 AM ET
Bristol-Myers Squibb Establishes Center for Molecular Synthesis in New Collaboration with Princeton University
Tuesday, December 8, 2015 4:10 pm EST, PRINCETON, N.J. /3BL Media/ - ...
Dec 8, 2015 4:10 PM ET